-+ 0.00%
-+ 0.00%
-+ 0.00%

Century Therapeutics Q4 EPS $(0.25) Beats $(0.27) Estimate

Benzinga·03/12/2026 12:21:10
Listen to the news
Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 8.42 percent. This is a 41.86 percent increase over losses of $(0.43) per share from the same period last year.